Your browser doesn't support javascript.
Knowledge of medical professionals, their practices, and their attitudes toward traditional Chinese medicine for the prevention and treatment of coronavirus disease 2019: A survey in Sichuan, China.
Pu, Jing; Mei, He; Lei, Li; Li, Daiwen; Zhao, Jiekun; Li, Bin; Wang, Haiyan; Ma, Ying; Du, Xiao Bo.
  • Pu J; Department of Traditional Chinese Medicine, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Mei H; Department of Nursing, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Lei L; Department of Traditional Chinese Medicine, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Li D; Department of Traditional Chinese Medicine, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Zhao J; Department of Traditional Chinese Medicine, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Li B; Department of Traditional Chinese Medicine, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Wang H; Department of Nursing, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Ma Y; Scientific Research and Education Department, Mianyang Central Hospital, Mianyang, Sichuan, China.
  • Du XB; Department of Oncology, Mianyang Central Hospital, Mianyang, Sichuan, China.
PLoS One ; 16(3): e0234855, 2021.
Article in English | MEDLINE | ID: covidwho-1136272
ABSTRACT
This study aimed to investigate the knowledge, practices, and attitudes of medical professionals toward Traditional Chinese Medicine (TCM) for the prevention and treatment of coronavirus disease 2019 (COVID-19). All 401 medical professionals were surveyed using an anonymous with an investigator using the Questionnaire star APP. The participants answered 14 questions; of the 401 participants, 55.2% agreed with the statement "TCM can be used for the prevention and treatment of COVID-19," 40.4% remained neutral, and 4.4% disagreed. Moreover, 75.3% agreed with the statement "There is no specific drug for COVID-19," 67% agreed with the statement "TCM can develop immunity to COVID-19" and 62.1% agreed with "TCM can alleviate the symptoms of patients with COVID-19." Meanwhile, 69.1% were aware that TCM has been recommended for COVID-19 by the National Health Commission of the People's Republic of China. Regarding the selection of sources of knowledge on whether "TCM can be used for the prevention and treatment of COVID-19," There were 277, 123, 82, 369, and 17 participants selected sources from "Hospital training," "Academic journals," "Academic Conferences," "Social media platforms (such as WeChat)" and "Others," respectively. Further, 358 participants will take TCM for the prevention of COVID-19. Multiple logistic regression analysis showed that age, major and received TCM treatment within the last five years were independent factors affecting the participants' attitudes. In the absence of specific drugs for COVID-19, more than half of the participants agreed that TCM could be used for the prevention and treatment of COVID-19 and most participants are willing to take TCM to prevent COVID-19, although unsure about its effectiveness. The main information sources on TCM for the treatment and prevention of COVID-19 were social platforms and hospital training.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Professional Practice / Attitude / Knowledge / Professionalism / COVID-19 / Medicine, Chinese Traditional Type of study: Observational study / Randomized controlled trials Topics: Traditional medicine Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0234855

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Professional Practice / Attitude / Knowledge / Professionalism / COVID-19 / Medicine, Chinese Traditional Type of study: Observational study / Randomized controlled trials Topics: Traditional medicine Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0234855